Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pre… Read more
Revenio Group Corporation (REG1V) - Net Assets
Latest net assets as of June 2025: €104.40 Million EUR
Based on the latest financial reports, Revenio Group Corporation (REG1V) has net assets worth €104.40 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€135.20 Million) and total liabilities (€30.80 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €104.40 Million |
| % of Total Assets | 77.22% |
| Annual Growth Rate | 6.93% |
| 5-Year Change | 54.51% |
| 10-Year Change | 616.48% |
| Growth Volatility | 68.78 |
Revenio Group Corporation - Net Assets Trend (2000–2024)
This chart illustrates how Revenio Group Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Revenio Group Corporation (2000–2024)
The table below shows the annual net assets of Revenio Group Corporation from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €107.71 Million | +7.82% |
| 2023-12-31 | €99.89 Million | +9.87% |
| 2022-12-31 | €90.92 Million | +15.92% |
| 2021-12-31 | €78.43 Million | +12.51% |
| 2020-12-31 | €69.71 Million | +8.31% |
| 2019-12-31 | €64.36 Million | +256.17% |
| 2018-12-31 | €18.07 Million | +13.03% |
| 2017-12-31 | €15.99 Million | +6.81% |
| 2016-12-31 | €14.97 Million | -0.43% |
| 2015-12-31 | €15.03 Million | +24.64% |
| 2014-12-31 | €12.06 Million | -19.36% |
| 2013-12-31 | €14.96 Million | +1.91% |
| 2012-12-31 | €14.68 Million | -10.66% |
| 2011-12-31 | €16.43 Million | +13.28% |
| 2010-12-31 | €14.50 Million | -7.87% |
| 2009-12-31 | €15.74 Million | -10.52% |
| 2008-12-31 | €17.59 Million | -20.83% |
| 2007-12-31 | €22.22 Million | +102.72% |
| 2006-12-31 | €10.96 Million | +118.46% |
| 2005-12-31 | €5.02 Million | +132.65% |
| 2004-12-31 | €2.16 Million | +95.66% |
| 2003-12-31 | €1.10 Million | -74.49% |
| 2002-12-31 | €4.32 Million | -46.35% |
| 2001-12-31 | €8.05 Million | -54.55% |
| 2001-09-30 | €17.72 Million | -17.81% |
| 2000-12-31 | €21.56 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Revenio Group Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2610100.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €52.20 Million | 48.47% |
| Common Stock | €5.32 Million | 4.93% |
| Other Comprehensive Income | €51.86 Million | 48.15% |
| Total Equity | €107.71 Million | 100.00% |
Revenio Group Corporation Competitors by Market Cap
The table below lists competitors of Revenio Group Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Anterix Inc
NASDAQ:ATEX
|
$481.87 Million |
|
Beijing Chieftain Control Engineering Technology Co Ltd
SHE:300430
|
$481.93 Million |
|
Fukuyama Transporting Co. Ltd
F:FUY
|
$482.01 Million |
|
Cheng Du Sheng Nuo Biotec Co. Ltd. A
SHG:688117
|
$482.15 Million |
|
Fujian Apex Software Co Ltd
SHG:603383
|
$481.43 Million |
|
Zhejiang Kingland Pipeline and Technologies Co Ltd
SHE:002443
|
$481.43 Million |
|
Gulf Keystone Petroleum Ltd
PINK:GUKYF
|
$481.40 Million |
|
Changbai Mountain Tourism Co Ltd
SHG:603099
|
$481.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Revenio Group Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 99,894,000 to 107,709,000, a change of 7,815,000 (7.8%).
- Net income of 18,497,000 contributed positively to equity growth.
- Dividend payments of 10,105,000 reduced retained earnings.
- Other comprehensive income decreased equity by 943,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €18.50 Million | +17.17% |
| Dividends Paid | €10.11 Million | -9.38% |
| Other Comprehensive Income | €-943.00K | -0.88% |
| Other Changes | €366.00K | +0.34% |
| Total Change | €- | 7.82% |
Book Value vs Market Value Analysis
This analysis compares Revenio Group Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.37x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 47.50x to 4.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €0.37 | €17.70 | x |
| 2003-12-31 | €0.07 | €17.70 | x |
| 2004-12-31 | €0.15 | €17.70 | x |
| 2005-12-31 | €0.27 | €17.70 | x |
| 2008-12-31 | €0.77 | €17.70 | x |
| 2009-12-31 | €0.68 | €17.70 | x |
| 2010-12-31 | €0.63 | €17.70 | x |
| 2011-12-31 | €0.70 | €17.70 | x |
| 2012-12-31 | €0.63 | €17.70 | x |
| 2013-12-31 | €0.63 | €17.70 | x |
| 2014-12-31 | €0.51 | €17.70 | x |
| 2015-12-31 | €0.65 | €17.70 | x |
| 2016-12-31 | €0.66 | €17.70 | x |
| 2017-12-31 | €0.67 | €17.70 | x |
| 2018-12-31 | €0.76 | €17.70 | x |
| 2019-12-31 | €2.50 | €17.70 | x |
| 2020-12-31 | €2.62 | €17.70 | x |
| 2021-12-31 | €2.95 | €17.70 | x |
| 2022-12-31 | €3.42 | €17.70 | x |
| 2023-12-31 | €3.76 | €17.70 | x |
| 2024-12-31 | €4.05 | €17.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Revenio Group Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.17%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 17.87%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 1.31x
- Recent ROE (17.17%) is above the historical average (-3.14%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -178.44% | -24.08% | 2.68x | 2.76x | €-8.14 Million |
| 2003 | -292.22% | -14.24% | 3.46x | 5.92x | €-3.33 Million |
| 2004 | -47.21% | -5.52% | 3.27x | 2.61x | €-1.23 Million |
| 2005 | 56.93% | 19.83% | 1.06x | 2.70x | €1.87 Million |
| 2006 | 31.52% | 24.17% | 0.83x | 1.57x | €2.36 Million |
| 2007 | 24.64% | 22.18% | 0.61x | 1.83x | €3.25 Million |
| 2008 | 15.15% | 5.90% | 1.56x | 1.65x | €906.00K |
| 2009 | -5.18% | -2.72% | 1.13x | 1.69x | €-2.39 Million |
| 2010 | -3.50% | -1.72% | 1.20x | 1.69x | €-1.96 Million |
| 2011 | 23.81% | 11.75% | 1.34x | 1.51x | €2.27 Million |
| 2012 | -1.96% | -1.13% | 1.02x | 1.70x | €-1.75 Million |
| 2013 | 29.00% | 16.86% | 1.14x | 1.51x | €2.84 Million |
| 2014 | -5.75% | -4.33% | 0.83x | 1.60x | €-1.90 Million |
| 2015 | 41.78% | 32.08% | 1.10x | 1.18x | €4.94 Million |
| 2016 | 35.45% | 23.83% | 1.23x | 1.20x | €4.01 Million |
| 2017 | 42.84% | 25.57% | 1.41x | 1.19x | €5.25 Million |
| 2018 | 44.84% | 26.43% | 1.39x | 1.22x | €6.30 Million |
| 2019 | 14.52% | 18.88% | 0.45x | 1.71x | €2.91 Million |
| 2020 | 19.17% | 21.88% | 0.53x | 1.64x | €6.39 Million |
| 2021 | 22.08% | 21.99% | 0.63x | 1.59x | €9.48 Million |
| 2022 | 23.93% | 22.43% | 0.71x | 1.50x | €12.66 Million |
| 2023 | 19.13% | 19.79% | 0.70x | 1.38x | €9.12 Million |
| 2024 | 17.17% | 17.87% | 0.73x | 1.31x | €7.73 Million |
Industry Comparison
This section compares Revenio Group Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $23,422,617
- Average return on equity (ROE) among peers: -1.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Revenio Group Corporation (REG1V) | €104.40 Million | -178.44% | 0.30x | $481.80 Million |
| Biohit Oyj B (BIOBV) | $13.41 Million | -6.25% | 1.04x | $19.87 Million |
| BBS-Bioactive Bone Substitutes Oyj (BONEH) | $4.42 Million | 8.60% | 1.53x | $854.55K |
| Modulight Oyj (MODU) | $76.15 Million | -6.65% | 0.15x | $17.65 Million |
| Nexstim Oyj (NXTMH) | $-294.27K | 0.00% | 0.00x | $35.65 Million |